Evidence map›Paper›PMID 27529215›Full record

ArticleInternational journal of molecular sciences2016

ST6GALNAC5 Expression Decreases the Interactions between Breast Cancer Cells and the Human Blood-Brain Barrier.

Aurore Drolez, Elodie Vandenhaute, Clément Philippe Delannoy, Justine Hélène Dewald, Fabien Gosselet, Romeo Cecchelli, Sylvain Julien, Marie-Pierre Dehouck, Philippe Delannoy, Caroline Mysiorek

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Targeting of endothelial cells in brain tumours.Clinical and translational medicine · 2023
    Review
  8. Article
  9. Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. American journal of cancer research · 2022
    Article
  15. Review
  16. Article
  17. miR-182 modulates cell proliferation and invasion in prostate cancer via targeting ST6GALNAC5.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Aurore DrolezUniversité d'Artois (UArtois), EA2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens F-62300, France. aurore.drolez@univ-artois.fr.
Elodie VandenhauteUniversité d'Artois (UArtois), EA2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens F-62300, France. elodie.vandenhaute@univ-artois.fr.
Clément Philippe DelannoyStructural and Functional Glycobiology Unit, Unité Mixte de Recherche (UMR) du Centre National de la Recherche Scientifique (CNRS) 8576, University of Lille, Villeneuve d'Ascq F-59655, France. cl-ment.delannoy@etudiant.univ-lille1.fr.
Justine Hélène DewaldStructural and Functional Glycobiology Unit, Unité Mixte de Recherche (UMR) du Centre National de la Recherche Scientifique (CNRS) 8576, University of Lille, Villeneuve d'Ascq F-59655, France. justine.dewald@etudiant.univ-lille1.fr.
Fabien GosseletUniversité d'Artois (UArtois), EA2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens F-62300, France. fabien.gosselet@univ-artois.fr.
Romeo CecchelliUniversité d'Artois (UArtois), EA2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens F-62300, France. romeo.cecchelli@univ-artois.fr.
Sylvain JulienCell Plasticity and Cancer, U908 INSERM, University of Lille, Villeneuve d'Ascq F-59655, France. sylvain.julien@univ-lille1.fr.
Marie-Pierre DehouckUniversité d'Artois (UArtois), EA2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens F-62300, France. mpierre.dehouck@univ-artois.fr.
Philippe DelannoyStructural and Functional Glycobiology Unit, Unité Mixte de Recherche (UMR) du Centre National de la Recherche Scientifique (CNRS) 8576, University of Lille, Villeneuve d'Ascq F-59655, France. philippe.delannoy@univ-lille1.fr.
Caroline MysiorekUniversité d'Artois (UArtois), EA2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Lens F-62300, France. caroline.mysiorek@univ-artois.fr.
Université d'Artois · FRCentre National de la Recherche Scientifique · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ST6GALNAC5 gene that encodes an α2,6-sialyltransferase involved in the biosynthesis of α-series gangliosides, was previously identified as one of the genes that mediate breast cancer metastasis to the brain. We have shown that the expression of ST6GALNAC5 in MDA-MB-231 breast cancer cells resulted in the expression of GD1α ganglioside at the cell surface. By using a human blood-brain barrier in vitro model recently developed, consisting in CD34⁺ derived endothelial cells co-cultivated with pericytes, we show that ST6GALNAC5 expression decreased the interactions between the breast cancer cells and the human blood-brain barrier.

Indexed as

AnimalsAntigens, CD34Blood-Brain BarrierBreast NeoplasmsCell Line, TumorFemaleG(M1) GangliosideHumansMicePericytesSialyltransferasesAntigens, CD34ganglioside GD1alphaG(M1) GangliosideSialyltransferasesblood-brain barrierbrain metastasisbreast cancergangliosidesGD1αsialyltransferaseST6GALNAC5

Identifiers

PMID27529215
PMCPMC5000706
OpenAlexW2514584126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.